Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Approval for controlled-release carbamazepine tablets

Sep. 27, 1996

Approval sought for antidepressant from Pharmacia & Upjohn

Sep. 27, 1996

New anxiolytic from SmithKline Beecham

Sep. 27, 1996

Egis claims new anxiolytics with a favorable side effect profile

Sep. 27, 1996

Roche Bioscience-Signal drug discovery collaboration

Sep. 27, 1996

SNX-111 development re-scheduled

Sep. 27, 1996

Sanofi reports tachykinin antagonists

Sep. 27, 1996

Glutamate inhibitor progresses through the pipeline

Sep. 20, 1996

Another series of mGluR antagonists from Lilly

Sep. 20, 1996

Metabotropic glutamate receptor antagonists from Lilly

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026